Terri B. Sebree
2018
In 2018, Terri B. Sebree earned a total compensation of $1.3M as President at Zynerba Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $227,849 |
---|---|
Option Awards | $590,606 |
Salary | $437,750 |
Other | $24,826 |
Total | $1,281,031 |
Sebree received $590.6K in option awards, accounting for 46% of the total pay in 2018.
Sebree also received $227.8K in non-equity incentive plan, $437.8K in salary and $24.8K in other compensation.
Rankings
In 2018, Terri B. Sebree's compensation ranked 7,960th out of 14,244 executives tracked by ExecPay. In other words, Sebree earned more than 44.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,960 | 44th |
Manufacturing | 3,126 | 46th |
Chemicals And Allied Products | 1,166 | 45th |
Drugs | 979 | 46th |
Pharmaceutical Preparations | 760 | 45th |
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2018.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019